Ainos Achieves 499% Growth, 82.9% Margin and Scales Semiconductor Deployments
Ainos reported 499% revenue growth in 2025 with gross margin improving to 82.9% as operating expenses ex-noncash items fell 9% year-over-year. The company secured NT$90 million (~$2.8 million) financing and launched early semiconductor deployments, including 200 front-end wafer systems and 1,400 units under a $2.1 million agreement.
1. 2025 Financial Performance
Ainos reported a 499% year-over-year revenue increase in 2025, driven by AI Nose commercialization across industrial and healthcare sectors. Gross margin turned positive at 82.9%, while operating expenses excluding share-based compensation, depreciation and amortization declined 9% despite a 2% rise in reported operating costs.
2. Financing and Operational Discipline
After year-end, Ainos raised NT$90 million (approximately USD 2.82 million) to bolster liquidity for ongoing operations and deployment execution. The financing enhances the company’s capital flexibility as it scales its SmellTech-as-a-Service model and maintains disciplined cost management.
3. Semiconductor Deployment Momentum
In 1Q 2026, Ainos launched early AI Nose deployments with 200 systems in front-end wafer fabrication facilities for technical validation and 1,400 systems under a three-year $2.1 million agreement for packaging and testing. These installations aim to generate data for the Smell Language Model and set the stage for scaling to up to 20,000 units pending validation.